{"result": {"id": "74b3cd57-242a-4abb-b868-dfc5d8530497", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>HIGH CHOLESTEROL<|>EVENT<|>High cholesterol is a condition where serum total cholesterol levels are elevated, often coexisting with hypertension and increasing the risk of coronary heart disease\")  \n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a condition characterized by high blood pressure, often coexisting with high cholesterol and increasing the risk of coronary heart disease\")  \n##\n(\"entity\"<|>CORONARY HEART DISEASE<|>EVENT<|>Coronary heart disease is caused by atherosclerosis of the coronary arteries, leading to narrowed arteries and increased risk of heart attacks and other complications\")  \n##\n(\"entity\"<|>BILE ACID BINDING RESINS<|>ORGANIZATION<|>Bile acid binding resins are a class of lipid-lowering drugs that can interfere with the absorption of certain antihypertensive drugs\")  \n##\n(\"entity\"<|>FIBRIC ACID DERIVATIVES<|>ORGANIZATION<|>Fibric acid derivatives are a class of lipid-lowering drugs that may cause myopathy in some patients with renal failure\")  \n##\n(\"entity\"<|>NIACIN<|>ORGANIZATION<|>Niacin is a lipid-lowering drug that can enhance the vasodilatory effects of antihypertensive drugs, potentially causing blood pressure to drop\")  \n##\n(\"entity\"<|>STATINS<|>ORGANIZATION<|>Statins are a class of lipid-lowering drugs that do not have significant interactions with antihypertensive drugs\")  \n##\n(\"entity\"<|>POLYENOIC ACID<|>ORGANIZATION<|>Polyenoic acid is a lipid-lowering drug that does not have significant interactions with antihypertensive drugs\")  \n##\n(\"entity\"<|>FISH OIL LIPID-LOWERING PILLS<|>ORGANIZATION<|>Fish oil lipid-lowering pills are a class of lipid-lowering drugs that do not have significant interactions with antihypertensive drugs\")  \n##\n(\"relationship\"<|>HIGH CHOLESTEROL<|>HYPERTENSION<|>High cholesterol and hypertension often coexist and synergistically increase the risk of coronary heart disease<|>8)  \n##\n(\"relationship\"<|>HIGH CHOLESTEROL<|>CORONARY HEART DISEASE<|>High cholesterol contributes to the development of coronary heart disease through atherosclerosis<|>9)  \n##\n(\"relationship\"<|>HYPERTENSION<|>CORONARY HEART DISEASE<|>Hypertension increases the risk of coronary heart disease<|>8)  \n##\n(\"relationship\"<|>BILE ACID BINDING RESINS<|>HYPERTENSION<|>Bile acid binding resins can interfere with the absorption of certain antihypertensive drugs<|>6)  \n##\n(\"relationship\"<|>FIBRIC ACID DERIVATIVES<|>HYPERTENSION<|>Fibric acid derivatives may cause myopathy in some patients with renal failure, requiring careful dosing and monitoring<|>5)  \n##\n(\"relationship\"<|>NIACIN<|>HYPERTENSION<|>Niacin can enhance the vasodilatory effects of antihypertensive drugs, potentially causing blood pressure to drop<|>7)  \n##\n(\"relationship\"<|>STATINS<|>HYPERTENSION<|>Statins do not have significant interactions with antihypertensive drugs and can be used in patients with both high cholesterol and hypertension<|>4)  \n##\n(\"relationship\"<|>POLYENOIC ACID<|>HYPERTENSION<|>Polyenoic acid does not have significant interactions with antihypertensive drugs and can be used in patients with both high cholesterol and hypertension<|>4)  \n##\n(\"relationship\"<|>FISH OIL LIPID-LOWERING PILLS<|>HYPERTENSION<|>Fish oil lipid-lowering pills do not have significant interactions with antihypertensive drugs and can be used in patients with both high cholesterol and hypertension<|>4)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166249, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 893, "prompt_tokens": 2324, "total_tokens": 3217, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 532}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 危险因素 时，应配伍应用抗高脂血症药物。\n摇摇源援高血压伴高脂血症的降脂药选择\n　　　高胆固醇血症和高血压病，常常是相互伴发的两种疾病。在 美国一项 缘员园万例高血压病人中的调查发现，源园豫的高血压病\n病人血清总胆固醇水平 跃远援圆毫摩尔辕升（圆源园毫克辕分升），而血\n清总胆固醇水平 跃远援圆毫摩尔辕升的高胆固醇血症病人中，源远豫患 有高血压。血压越高，冠心病的危险性越大。血清总胆固醇水平 升高，对高血压病病人的冠心病危险起协同增加作用。而降低血 压和降低血清总胆固醇水平，可以减少冠心病的危险。\n　　胆酸结合树脂、纤维酸衍生物、烟酸及其衍生物等降脂药物均 可以用于高脂血症伴高血压的病人。但是，应注意这些降脂药物 与抗高血压药物之间的相互影响。胆酸结合树脂可以减少噻嗪类 利尿剂和普萘洛尔（心得安）的吸收。因此，这些降压药必须在服 用胆酸结合树脂前 员小时或服用后的源小时才能服用。纤维酸衍 生物对某些肾功能衰竭的病人可能引起肌病，因此服用纤维酸衍 生物的剂量要小，并且经常随访病人。烟酸可以加强抗高血压药\n源                                                   ◆\n\n\n\n\n\t 七、高脂血症合并“危险伙伴”的防治         \n物的血管扩张作用而引起血压下降，应予以注意。他汀类降压药 物与抗高血压药物之间没有特别的相互作用，可以用于高脂血症 伴高血压病人的治疗。此外，多烯康、鱼油降脂丸等降脂药物与抗 高血压药物之间也没有特别的相互作用，也可用于高脂血症伴高 血压病人的降脂治疗。\n摇摇缘援冠心病合并高脂血症，降脂至关重要\n　　　高脂血症及动脉粥样硬化的形成，与冠心病的发生和发展关 系密切。临床研究证明，长期达标的降脂治疗可以减轻冠状动脉 狭窄，降低心肌梗死、猝死等发生率，减少冠状动脉支架置入术、冠 状动脉搭桥术等有创伤治疗的机会。\n　　　冠心病是由冠状动脉粥样硬化病变所引起，也就是说由于血  脂长期沉积于冠状动脉壁，形成斑块引起冠状动脉狭窄，最终导致  心\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_d331d5ce246dd84b881c56bb3127f8d093e16844289cb2a84d205e8d519cedc4_v2"}